INMUNE BIO INC. Other Nonoperating Expense
INMUNE BIO INC. (INMB) reported Other Nonoperating Expense of $267.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2024-03-28
- INMUNE BIO INC. other nonoperating expense for fiscal 2023 was $267.00K, a 80.19% decline from fiscal 2022.
- INMUNE BIO INC. other nonoperating expense for fiscal 2022 was $1.35M.
- INMUNE BIO INC. other nonoperating expense for fiscal 2017 was $6.00.
| Period end | Other Nonoperating Expense 12 month |
|---|---|
| 2023-12-31 | $267.00K 10-K · filed 2024-03-28 |
| 2022-12-31 | $1.35M 10-K · filed 2024-03-28 |
| 2017-12-31 | $6.00 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |